bit.bio raises $25M Series D as demand for its human cell models grows
Cambridge-based biotech company bit.bio has raised $25M in a Series D round, ten months after securing its previous investment. The company announced the new funding on Wednesday, with backing from existing investor M&G Investments and Dr Jonathan Milner…
Adjust this page to suit you. Your choices are saved in this browser.
Cookies. Chipokia uses one cookie, and only if you allow it: a random ID so your up and down votes stay yours. No analytics, no advertising, no tracking of any kind. Privacy & Cookie Policy.
